Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori

BACKGROUND: Helicobacter pylori (HP) infection is associated with reduced lung function and systemic inflammation in chronic obstructive pulmonary disease (COPD) patients. Azithromycin (AZ) is active against HP and reduces the risk of COPD exacerbation. We determined whether HP infection status modi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Respir Res
Autors principals: Ra, Seung Won, Sze, Marc A., Lee, Eun Chong, Tam, Sheena, Oh, Yeni, Fishbane, Nick, Criner, Gerard J., Woodruff, Prescott G., Lazarus, Stephen C., Albert, Richard, Connett, John E., Han, Meilan K., Martinez, Fernando J., Aaron, Shawn D., Reed, Robert M., Man, S. F. Paul, Sin, Don D.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5450077/
https://ncbi.nlm.nih.gov/pubmed/28558695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-017-0594-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars